U
HTG Molecular Diagnostics, Inc. HTGMQ
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income -7.22% -25.95% -36.01% -28.56% 7.24%
Total Depreciation and Amortization -31.19% -18.61% -26.86% -31.57% -40.73%
Total Amortization of Deferred Charges -21.08% -12.21% -5.37% -2.63% 8.42%
Total Other Non-Cash Items 1,404.65% 435.98% 179.87% 187.58% -94.49%
Change in Net Operating Assets 75.75% 85.54% 84.59% 78.73% 47.87%
Cash from Operations 6.98% -11.50% -18.63% -15.38% -8.25%
Capital Expenditure 96.23% 96.42% 87.74% -11.11% -5.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 64.64% 304.95% 432.98% 279.60% -83.50%
Cash from Investing 130.48% 286.36% 384.00% 256.75% -87.40%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -255.89% -915.96% -782.63% -326.61% 82.01%
Issuance of Common Stock -25.90% 42.67% -42.20% -45.57% -9.19%
Repurchase of Common Stock -5,301.96% -16,836.36% -14,615.79% -7,535.29% -24.39%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 44.13% -4.32% 26.62% 30.49% 32.48%
Cash from Financing -81.67% -17.19% -92.87% -70.43% -26.42%
Foreign Exchange rate Adjustments 112.00% 60.87% -1,140.00% -377.38% -214.94%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -62.19% 120.40% 18.92% -5.13% -188.39%
Weiss Ratings